Martha J Demski - Net Worth and Insider Trading
Martha J Demski Net Worth
The estimated net worth of Martha J Demski is at least $192,132 dollars as of 2023-09-26. Martha J Demski is the Director of Adamas Pharmaceuticals Inc and owns about 13,000 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $106,860. Martha J Demski is the Director of Chimerix Inc and owns about 72,055 shares of Chimerix Inc (CMRX) stock worth over $70,614. Martha J Demski is also the Director of ADMA Biologics Inc and owns about 4,200 shares of ADMA Biologics Inc (ADMA) stock worth over $14,658. Details can be seen in Martha J Demski's Latest Holdings Summary section.
Transaction Summary of Martha J Demski
Martha J Demski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martha J Demski owns 7 companies in total, including ADMA Biologics Inc (ADMA) , Chimerix Inc (CMRX) , and Adamas Pharmaceuticals Inc (ADMS) among others .
Click here to see the complete history of Martha J Demski’s form 4 insider trades.
Insider Ownership Summary of Martha J Demski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMA | ADMA Biologics Inc | 2022-03-07 | director |
| CMRX | Chimerix Inc | 2013-04-10 | director |
| ADMS | Adamas Pharmaceuticals Inc | 2020-06-03 | director |
| EQ | Equillium Inc | 2018-10-11 | director |
| EVFM | Evofem Biosciences Inc | 2014-11-19 | director |
| FRTX | Fresh Tracks Therapeutics Inc | 2004-05-21 | Vice President & CFO |
| TKNO | Alpha Teknova Inc | 2023-08-31 | director |
Martha J Demski Latest Holdings Summary
Martha J Demski currently owns a total of 3 stocks. Among these stocks, Martha J Demski owns 13,000 shares of Adamas Pharmaceuticals Inc (ADMS) as of April 9, 2014, with a value of $106,860 and a weighting of 55.62%. Martha J Demski owns 72,055 shares of Chimerix Inc (CMRX) as of May 10, 2023, with a value of $70,614 and a weighting of 36.75%. Martha J Demski also owns 4,200 shares of ADMA Biologics Inc (ADMA) as of September 11, 2020, with a value of $14,658 and a weighting of 7.63%.
Latest Holdings of Martha J Demski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2014-04-09 | 13,000 | 8.22 | 106,860 |
| CMRX | Chimerix Inc | 2023-05-10 | 72,055 | 0.98 | 70,614 |
| ADMA | ADMA Biologics Inc | 2020-09-11 | 4,200 | 3.49 | 14,658 |
Holding Weightings of Martha J Demski
Martha J Demski Form 4 Trading Tracker
According to the SEC Form 4 filings, Martha J Demski has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 0 shares on April 9, 2014, which brought Martha J Demski around $0.
According to the SEC Form 4 filings, Martha J Demski has made a total of 6 transactions in Chimerix Inc (CMRX) over the past 5 years, including 3 buys and 3 sells. The most-recent trade in Chimerix Inc is the acquisition of 18,000 shares on May 10, 2023, which cost Martha J Demski around $19,980.
According to the SEC Form 4 filings, Martha J Demski has made a total of 2 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ADMA Biologics Inc is the acquisition of 2,200 shares on September 11, 2020, which cost Martha J Demski around $5,038.
Insider Trading History of Martha J Demski
- 1
Martha J Demski Trading Performance
GuruFocus tracks the stock performance after each of Martha J Demski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martha J Demski is -8.26%. GuruFocus also compares Martha J Demski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martha J Demski within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martha J Demski's insider trading performs compared to the benchmark.
Performance of Martha J Demski
Average Relative Return
-25.69%
Outperforming Transactions
20%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 3.67 | -8.26 | -5.96 | -25.69 | 11.94 | -1.81 |
| Relative Return to S&P 500(%) | 2.56 | -14.53 | -16.63 | -45.05 | -3.52 | -13.44 |
Martha J Demski Ownership Network
Ownership Network List of Martha J Demski
Ownership Network Relation of Martha J Demski
Martha J Demski Owned Company Details
What does ADMA Biologics Inc do?
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
Who are the key executives at ADMA Biologics Inc?
Martha J Demski is the director of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include EVP & CFO Brian Lenz , director & President and CEO Adam S Grossman , and 10 percent owner Joseph Edelman .
ADMA Biologics Inc (ADMA) Insider Trades Summary
Over the past 18 months, Martha J Demski made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 382,769 shares made by Brian Lenz , and a net sale of 1,433,304 shares made by Bryant Fong .
In summary, during the past 3 months, insiders sold 2,583,538 shares of ADMA Biologics Inc (ADMA) in total and bought 155,000 shares, with a net sale of 2,428,538 shares. During the past 18 months, 2,583,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 2,391,580 shares.
ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ADMA Biologics Inc Insider Transactions
Martha J Demski Mailing Address
Above is the net worth, insider trading, and ownership report for Martha J Demski. You might contact Martha J Demski via mailing address: 7770 Regents Road Suite 113-505, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
